05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2025

May 17, 2025, 12:34 | Blog
U.S. FDA will Host Independent and Scientific Expert Panel Open to Public
U.S. FDA posted on X: "As part of the Trump Administration’s commitment to transform American…
May 17, 2025, 12:24 | Blog
Mark Yarchoan: Recent Advances in Therapeutic Cancer Vaccines
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared a recent article by him and…
May 17, 2025, 12:16 | Blog
Luis Lara-Mejía: Early Resistance in ALK+ NSCLC Targeted with Alectinib and Bevacizumab Combo
Luis Lara-Mejía, Medical Oncologist Specialized in Thoracic Neoplasms at National Institute of Cancerology, posted on…
May 17, 2025, 12:09 | Blog
Oscar Arrieta: Alectinib Plus Bevacizumab as First-Line Treatment in ALK-Rearranged NSCLC
Oscar Arrieta, Head of the Thoracic Oncology Unit at National institute of Oncology in Mexico,…
May 17, 2025, 11:55 | Blog
Jordi Remon Highlights EORTC Lung Cancer Group’s Spring Meeting in Genova
Jordi Remon, Thoracic Oncologist at CIOCC Barcelona, shared a post on X: "Cooperative Academic groups…
May 17, 2025, 11:48 | Science
Raffaele Colombo: The Therapeutic Window of Antibody-Drug Conjugates
Raffaele Colombo, Associate Director, Medicinal Chemistry at Zymeworks Inc., posted on X: "The tyranny of…
May 17, 2025, 11:40 | Blog
Sachin Jain: Dismantling Medicine’s White Wall of Silence
Sachin Jain, President and CEO of SCAN Group, posted on LinkedIn: "In law enforcement, the…
May 17, 2025, 11:33 | Blog
Peter Pisters: MD Anderson and Texas Children’s Launch Kinder Children’s Cancer Center to End Childhood Cancer
Peter Pisters, President of MD Anderson Cancer Center, shared a post on LinkedIn by MD…
May 17, 2025, 11:26 | Blog
Matthew Zachary: Remembering Ryan O'Donoghue - A Giant in Cancer Advocacy
Matthew Zachary, American advocate, Entertainer and Speaker, posted on LinkedIn: "The cancer advocacy world lost…
May 17, 2025, 10:33 | Blog
HYPART Trial: Testing 1-Week vs. 2-Week Radiotherapy for High-Risk Breast Cancer at ESMO Breast 2025
At the ESMO Breast Cancer Congress 2025 Dr. Budhi S. Yadav  (Chandigarh, India) presented finding from…
All: 2618 Posts: 1081 - 1090
Special Coverage